triamterene has been researched along with Proteinuria in 5 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both amiloride and triamterene significantly reduced proteinuria in patients with proteinuric kidney disease." | 9.41 | The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease. ( Alshehri, M; Desale, S; Shen, W; Wilcox, C, 2021) |
| "Both amiloride and triamterene significantly reduced proteinuria in patients with proteinuric kidney disease." | 5.41 | The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease. ( Alshehri, M; Desale, S; Shen, W; Wilcox, C, 2021) |
| "Amiloride has a significant role in the reduction of podocyte cell motility in vitro and proteinuria in mice." | 5.38 | Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria. ( Shi, W; Xie, S; Yang, Y; Zhang, B, 2012) |
| "Amiloride has a significant role in the reduction of podocyte cell motility in vitro and proteinuria in mice." | 1.38 | Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria. ( Shi, W; Xie, S; Yang, Y; Zhang, B, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, W | 1 |
| Alshehri, M | 1 |
| Desale, S | 1 |
| Wilcox, C | 1 |
| Zhang, B | 1 |
| Xie, S | 1 |
| Shi, W | 1 |
| Yang, Y | 1 |
| Schwenger, V | 1 |
| Zeier, M | 1 |
| Ritz, E | 1 |
| Riechers, G | 1 |
| Futerova, M | 1 |
| Hanisch, M | 1 |
| Ritter, W | 1 |
| Kühn, K | 1 |
| Clancy, RL | 1 |
| Stiel, JN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Crossover Pilot Study of the Effect of Amiloride on Proteinuria in Patients With Proteinuric Kidney Disease[NCT02522650] | Phase 4 | 30 participants (Anticipated) | Interventional | 2013-07-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for triamterene and Proteinuria
| Article | Year |
|---|---|
The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease.
Topics: Adult; Aged; Amiloride; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 2021 |
Effects of muzolimine and of a combination of hydrochlorothiazide/triamterene in healthy subjects and in nephrotic patients.
Topics: Adolescent; Adult; Aged; Body Weight; Creatinine; Drug Therapy, Combination; Electrolytes; Female; H | 1985 |
3 other studies available for triamterene and Proteinuria
| Article | Year |
|---|---|
Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria.
Topics: Amiloride; Animals; Cell Movement; Cells, Cultured; Disease Models, Animal; Epithelial Sodium Channe | 2012 |
Antihypertensive therapy in renal patients - benefits and difficulties.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive A | 1999 |
Familial Mediterranean fever with amyloidosis.
Topics: Adult; Amyloid; Amyloidosis; Bendroflumethiazide; Blood Proteins; Diet Therapy; Electrophoresis; Eth | 1968 |